114694-10-9

Upstream product

• 114694-24-5 1-(2-Benzenesulfonyl-ethyl)-cyclopentanol 
• 114694-22-3 2-(1-hydroxycyclopentyl)ethyl 4-methylbenzenesulfonate 
• 114694-11-0 (5Z,7E)-(1S,3R,20S)-1,3-bis<(tert-butyldimethylsilyl)oxy>-9,10-seco-5,7,10(19)-pregnatriene-20-carboxylic acid methyl ester 
• 114694-12-1 (5Z,7E)-(1S,3R,20S)-1,3-bis<(tert-butyldimethylsilyl)oxy>-9,10-seco-22,23-dinor-5,7,10(19)-cholatrien-24-ol 
• 114694-16-5 (5Z,7E)-(1S,3R,20S)-1-hydroxy-3-acetoxy-9,10-seco-5,7,10⁽¹⁹⁾-pregnatriene-20-carboxylic acid methyl ester 
• 114694-17-6 (S)-2-{(1R,3aS,7aR)-4-[2-[(3S,5R)-3,5-Dihydroxy-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-propionic acid methyl ester 
• 97903-24-7 (5Z,7E)-(3S,20S)-3-hydroxy-9,10-seco-5,7,10⁽¹⁹⁾pregnatriene-20-carboxylic acid methyl ester 
• 114694-26-7 (1R,3aS,7aR)-1-[(R)-3-Benzenesulfonyl-1-methyl-4-(1-triethylsilanyloxy-cyclopentyl)-butyl]-4-[2-[(3S,5R)-3,5-bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-7a-methyl-octahydro-indene 
• 114694-13-2 (5Z,7E)-(1S,3R,20S)-1,3-bis<(tert-butyldimethylsilyl)oxy>-9,10-seco-22,23-dinor-5,7,10(19)-cholatrienol 22-p-toluenesulfonate 
• 97903-25-8 (S)-2-{(1R,3aS,7aR)-7a-Methyl-4-[2-[(S)-2-methylene-5-(toluene-4-sulfonyloxy)-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-octahydro-inden-1-yl}-propionic acid methyl ester 
• 114694-15-4 (S)-2-{(1R,3aS,7aR)-4-[(R)-2-((1R,3S,5R)-3-Hydroxy-2-methylene-bicyclo[3.1.0]hex-1-yl)-2-methoxy-eth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-propionic acid methyl ester 
• 97903-26-9 (7E)-(3R,5R,6R,20S)-6-methoxy-3,5-cyclo-9,10-seco-7,10⁽¹⁹⁾-pregnadiene-20-carboxylic acid methyl ester 
• 114694-25-6 1-<2-(phenylsulfonyl)ethyl>-1-<(triethylsilyl)oxy>cyclopentane 
• 114694-23-4 1-(2-Phenylsulfanyl-ethyl)-cyclopentanol 

Relevant academic research and scientific papers

Novel Convergent Synthesis of Side-Chain-Modified Analogues of 1α,25-Dihydroxycholecalciferol and 1α,25-Dihydroxyergocalciferol

A novel synthetic strategy for the preparation of side-chain-modified analogues of 1α,25-dihydroxycholecalciferol and 1α,25-dihydroxyergocalciferol was developed as a part of the extensive synthetic search for vitamin D analogues of potential anticancer a